FOLH1 and prostate carcinoma: Firstly, prostate cancer can express multiple tumor-associated antigens necessary in triggering anti-tumor immune response [such as prostate-specific antigen (PSA), prostatic acid phosphatase (PAP), prostate-specific membrane antigen (PSMA), and prostate stem cell antigen (PSCA)] [37, 38].